Separately, Credit Suisse Group boosted their target price on Coloplast A/S from 1,080.00 to 1,100.00 and gave the stock an outperform rating in a report on Thursday, September 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of Hold and an average price target of $1,023.33.
Coloplast A/S Trading Down 2.6 %
Shares of Coloplast A/S stock opened at $10.50 on Tuesday. The stock has a market cap of $22.69 billion, a P/E ratio of 35.02 and a beta of 0.28. The stock’s 50 day simple moving average is $11.60 and its 200-day simple moving average is $12.48. Coloplast A/S has a 1-year low of $10.18 and a 1-year high of $18.19. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.29 and a quick ratio of 0.90.
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- Get a free copy of the StockNews.com research report on Coloplast A/S (CLPBY)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.